Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 3, 2022
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
Matthew Harrison Upgraded (VRTX) to Hold and Held Target at $250 on, May 3rd, 2022
Matthew Harrison of Morgan Stanley, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Hold and Held Target at $250 on, May 3rd, 2022.
Matthew has made no other calls on VRTX in the last 4 months.
There are 9 other peers that have a rating on VRTX. Out of the 9 peers that are also analyzing VRTX, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Do Kim of "Piper Sandler" Maintained at Hold with Increased Target to $249 on, Friday, April 22nd, 2022
- Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $274 on, Wednesday, April 6th, 2022
- Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $222 on, Thursday, January 27th, 2022
These are the ratings of the 6 analyists that currently disagree with Matthew
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $322 on, Wednesday, April 27th, 2022
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $300 on, Tuesday, April 5th, 2022
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $350 on, Monday, April 4th, 2022
- Brian Skorney of "Baird" Maintained at Buy and Held Target at $240 on, Wednesday, March 23rd, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $275 on, Thursday, January 27th, 2022
- Evan Seigerman of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $274 on, Thursday, January 20th, 2022
